{"id":75625,"date":"2022-01-14T11:46:04","date_gmt":"2022-01-14T11:46:04","guid":{"rendered":"https:\/\/www.atlasrleye.com\/degenerative-myopia\/clinical-case-2\/"},"modified":"2024-03-20T14:22:12","modified_gmt":"2024-03-20T14:22:12","slug":"clinical-case-2","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/degenerative-myopia\/clinical-case-2\/","title":{"rendered":"Clinical Case 2"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”MACULAR DISEASES” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231636632711938-40a9cd41-6444|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Degenerative Myopia – Clinical Case 2″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fdegenerative-myopia%2F|title:DEGENERATIVE%20MYOPIA|”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”55233″ img_size=”medium” alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Fundus photograph of degenerative myopia in a 56-years-old female patient. Note the oblique insertion of the optic disc, the peripapillary atrophy (optic disc crescent) and the extensive areas of chorioretinal atrophy.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”55230″ img_size=”medium” alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text]<\/p>\n

Fluorescein angiogram at early phase, in the same case.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation – 02 09 2009″ tab_id=”1641394922374-47016b7f-6668″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52509,52536,52512,52539,52515,52518″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52533,52524,52530,52527″ img_size=”207×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52521″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation – 07 09 2009″ tab_id=”1642160324947-e07780d7-8017″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

One week after intraocular bevacizumab injection. The patient reported the improve of visual acuity.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52572″ img_size=”323×206″ css=”.vc_custom_1708637847510{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52557,52566,52560,52563″ img_size=”207×110″][vc_gallery type=”image_grid” images=”52542,52545,52548,52578,52575″ img_size=”410×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”2\/3″][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52551,52554″ img_size=”251×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Tonometry<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52569″ img_size=”206×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”3rd Evaluation – 10 01 2011″ tab_id=”1642160231484-5075a149-32e2″][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52599″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52593″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52581″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

Note the choroidal neovascular membrane and the lamellar hole.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52605,52584,52587,52590″ img_size=”410×110″ css=”.vc_custom_1708637535486{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n

\n

After 2 sessions of intraocular bevacizumab injection. Note the yellow collor of the macula typical of choroidal neovascular membrane.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52602″ img_size=”251×206″ css=”.vc_custom_1708637507910{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Tonometry<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52596″ img_size=”206×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”4th Evaluation 06 04 2011″ tab_id=”1642160607910-b7640e1e-9a9e”][vc_row_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52626″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52623″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52614″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52629″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

One year after the last intraocular bevacizumab injection.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52608,52617,52611,52620″ img_size=”410×110″ css=”.vc_custom_1708637569972{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”5th Evaluation – 07 03 2019″ tab_id=”1642160699650-62a91794-a501″][vc_row_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52650″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52641″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52653″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n

\n

BCVA: 20\/100 LE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52647″ img_size=”251×206″ css=”.vc_custom_1708637609635{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”52635,52638,52644,52632″ img_size=”410×110″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”6th Evaluation – 14 06 2023″ tab_id=”1710938767877-09133d26-8a8b”][vc_row_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”105695″ img_size=”251×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”105683″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”2\/4″][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

BVCA: 20\/50 RE.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”105687″ img_size=”300×206″ css=”.vc_custom_1710940478797{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”105699,105703,105675,105679″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”105691″ img_size=”251×206″ css=”.vc_custom_1710940548219{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”MACULAR DISEASES” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231636632711938-40a9cd41-6444|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Degenerative Myopia – Clinical Case 2″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fdegenerative-myopia%2F|title:DEGENERATIVE%20MYOPIA|”][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”55233″ img_size=”medium” alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text] Fundus photograph of […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":75601,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-75625","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=75625"}],"version-history":[{"count":19,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75625\/revisions"}],"predecessor-version":[{"id":105792,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75625\/revisions\/105792"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75601"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=75625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}